Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/603207 stock hub

SHA/603207 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/603207is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.3B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/603207

In the news

Latest news · SHA/603207

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E20.1

P25 23.5P50 41.3P75 83.2

ROE19

P25 -0.9P50 4.1P75 8.8

ROIC56.8

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/603207 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

193

Groups with data

Currency

CNY

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	404
Employees Change	-142%
Employees Change Percent	-26.01
Enterprise value	CNY 3.6B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	CNY 4.3B
Price	CNY 26.64
Price currency	CNY
Rev Per Employee	1,248,981.03x
Sector	Healthcare
Sic	2834
Symbol	sha/603207
Website	https://www.xf-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.98%
EV Earnings	17.08x
EV/EBIT	15.05x
EV/EBITDA	14.89x
EV/FCF	32.29x
EV/Sales	7.22x
FCF yield	2.64%
P/B ratio	4.06x
P/E ratio	20.06x
P/S ratio	8.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	48.01%
EBITDA Margin	48.42%
FCF margin	22.37%
Gross margin	66.3%
Gross Profit	CNY 334.6M
Gross Profit Growth	8.37%
Gross Profit Growth Q	27.77%
Net Income	CNY 213.5M
Net Income Growth	8.5%
Net Income Growth Q	28.45%
Pretax Margin	49.36%
Profit Margin	42.31%
Profit Per Employee	CNY 528,454
ROA	11.39
Roa5y	26.92
ROCE	22.98
ROE	19.02
Roe5y	51.73
ROIC	56.84
Roic5y	128

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.5%
EPS Growth	-16.17
EPS Growth Q	26.62
FCF Growth	-11.15%
OCF Growth	-17.02%
OCF Growth Q	1.78%
Revenue Growth	6.89x
Revenue Growth Q	35.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.38
Assets	CNY 1.3B
Cash	CNY 734.9M
Current Assets	CNY 882.9M
Current Liabilities	CNY 110.8M
Debt	CNY 1.8M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY 0.02
Equity	CNY 1.1B
Interest Coverage	18,887.1
Liabilities	CNY 253.5M
Long Term Assets	CNY 424.7M
Long Term Liabilities	CNY 142.7M
Net Cash	CNY 733.1M
Net Cash By Market Cap	CNY 17.11
Net Cash Growth	-27.5%
Net Debt EBITDA	CNY -3
Net Debt Equity	CNY -0.7
Net Debt FCF	CNY -6.49
Tangible Book Value	CNY 1B
Tangible Book Value Per Share	CNY 6.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.67
Inventory Turnover	3.61
Net Working Capital	CNY -55.4M
Quick ratio	3.35
Working Capital	CNY 677.7M
Working Capital Turnover	CNY 0.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.43%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CNY 1.4
Dividend Years	1
Dividend Yield	5.26%
Last Dividend	CNY 0.7
Payout Frequency	Semi-Annual
Payout Ratio	112.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.5%
200-day SMA	31.09
50-day SMA	27.75
50-day SMA vs 200-day SMA	50under200
All Time High	39.5
All Time High Change	-32.56%
All Time High Date	2024-08-27
All Time Low	20.5
All Time Low Change	29.95%
All Time Low Date	2024-09-18
ATR	0.59
Beta1y	0.31
Beta2y	0.65
Ch YTD	-6.92
High	26.64
High52	39.47
High52 Date	2025-08-04
High52ch	-32.51%
Low	26.15
Low52	25.48
Low52 Date	2026-03-23
Low52ch	4.55%
Ma50ch	-4.01%
Price vs 200-day SMA	-14.32%
RSI	42.21
RSI Monthly	43.45
RSI Weekly	34.34
Sharpe ratio	0.02x
Sortino ratio	0.23
Total Return	-24.18%
Tr YTD	-6.92
Tr1m	-3.37%
Tr1w	1.37%
Tr3m	-12.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 242.3M
Operating Income Growth	8.32
Operating Income Growth Q	41.18
Operating margin	48.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,820,000%
Net Borrowing	1,425,545
Shares Institutions	4.21%
Shares Out	160,820,000
Shares Qo Q	-1.96%
Shares Yo Y	29.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 112.1M
Average Volume	1,124,953.25x
Bv Per Share	6.64
CAPEX	CNY -65.6M
Ch1m	-3.37
Ch1w	1.37
Ch1y	-3.55
Ch3m	-12.57
Ch6m	-17.16
Change	1.68%
Change From Open	1.83
Close	26.2
Days Gap	-0.15
Depreciation Amortization	2,076,486
Dollar Volume	34,200,112.3
Earnings Date	2026-04-22
EBIT	CNY 242.3M
EBITDA	CNY 244.3M
EPS	CNY 1.33
F Score	4
FCF	CNY 112.9M
FCF EV Yield	3.1x
FCF Per Share	CNY 0.7
Financing CF	-236,120,043
Fiscal Year End	December
Founded	1,993
Graham Number	14.08928
Graham Upside	-47.11
Income Tax	CNY 35.6M
Investing CF	-81,803,672
Is Primary Listing	1
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Ma150	29.83
Ma150ch	-10.71%
Ma20	27.31
Ma20ch	-2.44%
Net CF	-139,447,811
Open	26.16
P FCF Ratio	37.95
P OCF Ratio	24
Payment Date	2025-10-20
Position In Range	100
Ppne	349,427,397
Price Date	2026-05-08
Price EBITDA	CNY 17.53
Ptbv Ratio	4.16
Relative Volume	1.14x
Revenue	504,588,338x
SBC By Revenue	0.16x
Share Based Comp	792,080
Tax By Revenue	7.05x
Tax Rate	14.28%
Tr6m	-17.16%
Volume	1,283,788

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/603207 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.3%

$1.40 annual per share

Payout ratio

+112.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-24.2%

Dividend yield + buyback yield combined

Performance

SHA/603207 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/603207?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.2%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+29.4%

Negative means the company is buying back shares.

Technical

SHA/603207 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.2

Neutral momentum band

Price vs 200-day MA

-14.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/603207

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/603207 stock rating?

sha/603207 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/603207 analysis?

The full report lives at /stocks/sha/603207/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/603207?

The latest report frames sha/603207 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/603207 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.